Special Issue: EACR 2026 Congress: Innovative Cancer Science, 8-11 June 2026

Molecular oncology · 2026 · vol. 20 Suppl 1(Suppl 1) , pp. 1–692 · doi:10.1002/1878-0261.70318 · PMID:42633749 · PMC13500139
Other OA: gold CC-BY-4.0
📄 Open PDF View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-09-25 ⓘ

This supplement of Molecular Oncology publishes abstracts accepted by the EACR 2026 Congress Organising Committee for the Innovative Cancer Science meeting held from June 8 to 11, 2026.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Abstracts submitted to the 'EACR 2026 Congress: Innovative Cancer Science', from 08-11 June 2026 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).

My notes (saved in your browser only)

MeSH descriptors

Neoplasms Neoplasms Humans

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-10-18T09:30:06.152893+00:00
pubmed
last seen: 2026-10-08T21:56:48.290841+00:00
License: CC-BY-4.0 · commercial use OK · attribution required
Per Europe PMC